Supriya Lifescience Ltd. (SUPRIYA): Supriya Lifescience Share Price rises 5.98% today as stock gains to Rs 993
- September 23, 2026
- Posted by: Harsh Piplani
- Category: News
Supriya Lifescience Share Price rose to Rs 993, up 5.98% from the previous close of Rs 937, with market capitalisation at Rs 7,541.24 crore. The move places Supriya Lifescience Ltd. in focus in today’s stock market today and adds to the latest Supriya Lifescience Stock News coverage around the share price rise. The supplied data confirms the price event, but it does not establish a company-specific catalyst. What it does show is a clear same-day gain from the day open of Rs 937 to the day high of Rs 993, with turnover of Rs 1 crore. For investors tracking Supriya Lifescience Share Price Today, the next useful checks are valuation, profitability, sector comparison and any fresh company update that may follow. Univest readers can use this as a factual Supriya Lifescience Share Price Update and stock analysis note.
Supriya Lifescience Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 993 |
| Previous Close | Rs 937 |
| Today's Move | Rs 56 (+5.98%) |
| Open | Rs 937 |
| High | Rs 993 |
| Low | Rs 937 |
| Turnover | Rs 1 crore |
| Market Capitalisation | Rs 7,541.24 crore |
| Market Cap Category | Mid Cap |
Supriya Lifescience Ltd. (SUPRIYA) rose to Rs 993 from the previous close of Rs 937, a move of Rs 56 or 5.98%. The stock opened at Rs 937, reached a high of Rs 993, recorded a low of Rs 937.
Supriya Lifescience Share Price today moved higher by Rs 56, or 5.98%, from Rs 937 to Rs 993. The day open was Rs 937, the day low was Rs 937 and the day high was Rs 993, which means the stock ended at the day’s highest reported level in the supplied data. Turnover stood at Rs 1 crore. This is the key factual read-through of today’s Supriya Lifescience Stock News: the share price gain is fully supported by the day’s price path, but the data does not confirm a company-specific reason. In plain terms, the event is a same-day price rise that puts Supriya Lifescience Share Price in the stock updates list for today. Univest notes the move as part of broader Supriya Lifescience Share News and Supriya Lifescience Share Price Live coverage.
Supriya Lifescience Ltd. (SUPRIYA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 7,541.24 crore |
| P/E Ratio | 38.02x |
| P/B Ratio | 6.17x |
| ROE | 19.06% |
| ROCE | 25.3% |
| EPS | Rs 24.65 |
| Book Value Per Share | Rs 151.81 |
| Dividend Yield | 0.11% |
Supriya Lifescience Ltd. (SUPRIYA) fundamental metrics show P/E 38.02x, P/B 6.17x, ROE 19.06%, ROCE 25.3%. These figures provide context only and are not a buy or sell signal.
Supriya Lifescience Ltd. has a market capitalisation of Rs 7541.24 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 38.02x, P/B at 6.17x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 19.06% and ROCE of 25.3%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 24.65, book value per share of Rs 151.81, dividend yield of 0.11%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.75x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 38.02x |
| Benchmark Median P/E | 31.75x |
| Benchmark Average P/E | 49.54x |
| Benchmark P/E Range | 3.48x to 765.12x |
| Company P/B Ratio | 6.17x |
| Benchmark Median P/B | 3x |
| Company ROE | 19.06% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 25.3% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 7,541.24 crore |
| Benchmark Median Market Cap | Rs 748.47 crore |
Supriya Lifescience Ltd. (SUPRIYA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Supriya Lifescience Ltd. (SUPRIYA) has a P/E ratio of 38.02x, which is above the benchmark median of 31.75x, a difference of +19.75%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Supriya Lifescience Ltd. (SUPRIYA) has a ROE of 19.06%, which is above the benchmark median of 11.7%, a difference of +62.91%. Supriya Lifescience Ltd. (SUPRIYA) has a ROCE of 25.3%, which is above the benchmark median of 13.46%, a difference of +87.96%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,48,195.77 | 36.58 | 5.12 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,50,389.96 | 84.8 | 14.04 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,88,966.75 | 87.04 | 21.15 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,860.07 | 25.66 | 4.3 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,11,888.39 | 33.1 | 3.17 | 11.83 | 16 |
Supriya Lifescience Ltd. (SUPRIYA) has a P/E ratio of 38.02x compared with the displayed peer median of 36.58x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 19.06% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 25.3% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Supriya Lifescience Ltd. (SUPRIYA) has a market capitalisation of Rs 7,541.24 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Supriya Lifescience
- Supriya Lifescience Share Price rose 5.98% today to Rs 993 from Rs 937.
- The day high, day low and day open were all Rs 993 or Rs 937 in the supplied data, showing a clear same-day move.
- Market capitalisation stands at Rs 7,541.24 crore, which places the company above the industry median in the supplied benchmark.
- P/E is 38.02, P/B is 6.17, ROE is 19.06% and ROCE is 25.3%, giving a full valuation and profitability snapshot.
- In the peer set, Supriya Lifescience Share Price sits below larger pharma names on market cap while showing stronger ROE than several listed peers.
About Supriya Lifescience
Supriya Lifescience Ltd. operates in the Pharmaceuticals & Drugs industry under the Healthcare sector. The supplied data does not provide a detailed business-segment breakdown, so the verified company description here is limited to the industry and sector context. What can be stated safely is that Supriya Lifescience Share Price is being tracked in the same healthcare universe as major listed pharmaceutical companies and API-linked peers. For readers of Supriya Lifescience Stock News, the company’s relevant position comes from its financial profile rather than from a broader operating narrative in the dataset.
From a market perspective, Supriya Lifescience is a listed healthcare company with a market cap of Rs 7,541.24 crore, EPS of Rs 24.65, book value of Rs 151.81 and dividend yield of 0.11%. Those figures make the company’s Share Price today easier to place within standard financial analysis. Univest uses this section to keep Supriya Lifescience Share Price coverage factual and company-led, without adding unsupported business claims or unverified operating detail.
Track Supriya Lifescience Share Price on Univest
Use Supriya Lifescience Ltd. (SUPRIYA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track Supriya Lifescience Share Price on Univest for live share price updates, fundamental ratios, shareholding pattern data, 52-week levels and market insights. The Univest stock page also helps users follow Supriya Lifescience Stock News, Supriya Lifescience Share News and fresh company updates in one place. For quick comparison, the same page also supports sector and peer reading for Supriya Lifescience Share Price Today.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Supriya Lifescience Share Price rising today?
Ans. The supplied data confirms that Supriya Lifescience Share Price rose 5.98% to Rs 993 today. It does not establish a company-specific catalyst, so the verified explanation is limited to the observed same-day price event.
What is Supriya Lifescience Share Price today?
Ans. Supriya Lifescience Share Price today is Rs 993, compared with the previous close of Rs 937. The day change is Rs 56, which equals a 5.98% rise in the supplied market data.
What is Supriya Lifescience market cap?
Ans. Supriya Lifescience has a market capitalisation of Rs 7,541.24 crore. In the supplied same-industry benchmark, that is above the median market cap of Rs 748.47 crore and below the industry average of Rs 14,370.3 crore.
How does Supriya Lifescience compare on valuation?
Ans. Supriya Lifescience has a P/E ratio of 38.02 and a P/B ratio of 6.17. Both are above the same-industry medians of 31.75 and 3, respectively, which frames the current valuation context.
What do Supriya Lifescience ROE and ROCE show?
Ans. Supriya Lifescience reports ROE of 19.06% and ROCE of 25.3%. Both are above the supplied industry medians, showing stronger return metrics than the benchmark midpoint in the same-industry comparison. ROE stands at 19.06%.
What do EPS, book value and dividend yield mean for Supriya Lifescience?
Ans. EPS is Rs 24.65, book value is Rs 151.81 and dividend yield is 0.11%. These figures help readers connect Supriya Lifescience Share Price with earnings per share, accounting net worth and payout history.
How does Supriya Lifescience compare with peers?
Ans. Supriya Lifescience has a smaller market cap than Sun Pharma, Divi’s, Torrent, Zydus and Cipla in the supplied peer set. Its ROE and ROCE are competitive, while its P/B is above several peers.
Should investors track Supriya Lifescience Share Price on Univest?
Ans. Univest can be used to track Supriya Lifescience Share Price today, fundamental ratios, shareholding pattern, 52-week levels and market insights. The platform helps readers follow the stock with a structured factual snapshot.
